These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27766510)

  • 21. [Ivabradine in patients with stable ischemic heart disease and left ventricular systolic dysfunction: the results of the BEAUTIFUL study].
    Filipovský J
    Vnitr Lek; 2009 May; 55(5):513-6. PubMed ID: 19514618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ivabradine: the hope for a good treatment of ischemic heart disease.
    Riccioni G
    Curr Med Chem; 2013; 20(14):1817-23. PubMed ID: 23394554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Selective I(f) channel inhibition: an alternative for treating coronary artery disease?].
    Schipke JD; Büter I; Hohlfeld T; Schmitz-Spanke S; Gams E
    Herz; 2006 Feb; 31(1):55-74. PubMed ID: 16502273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ivabradine on central aortic blood pressure in patients with stable coronary artery disease: What do we know?
    Lopatin YM; Vitale C
    Int J Cardiol; 2016 Dec; 224():145-148. PubMed ID: 27657463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.
    Ferrari R; Ceconi C
    Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):959-73. PubMed ID: 21878041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future directions: what data do we need?
    Tendera M
    Adv Cardiol; 2006; 43():106-111. PubMed ID: 16936476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Heart rate modulation in stable ischemic heart disease: what we have learned from the SIGNIFY study?].
    Perna GP; Battistoni I; Angelini L
    G Ital Cardiol (Rome); 2015 Mar; 16(3):155-60. PubMed ID: 25837459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization.
    Zarifis J; Grammatikou V; Kallistratos M; Katsivas A
    Angiology; 2017 Jan; 68(1):10-18. PubMed ID: 26960667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction.
    Rosano GM; Vitale C; Volterrani M
    Adv Ther; 2010 Apr; 27(4):202-10. PubMed ID: 20495895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ivabradine, coronary artery disease, and heart failure: beyond rhythm control.
    Scicchitano P; Cortese F; Ricci G; Carbonara S; Moncelli M; Iacoviello M; Cecere A; Gesualdo M; Zito A; Caldarola P; Scrutinio D; Lagioia R; Riccioni G; Ciccone MM
    Drug Des Devel Ther; 2014; 8():689-700. PubMed ID: 24940047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
    DiFrancesco D; Camm JA
    Drugs; 2004; 64(16):1757-65. PubMed ID: 15301560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of a pure reduction in heart rate for the treatment of left ventricular dysfunction: clinical benefits of ivabradine in the BEAUTIFUL trial.
    Danchin N
    Therapie; 2009; 64(2):111-4. PubMed ID: 19664404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A; de Silva R
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A New Insight on Anti-Ischemic Action of Ivabradine in Patients With Stable Angina].
    Kobalava ZD; Shavarov AA; Kiyakbaev GK
    Kardiologiia; 2017 Mar; 57(3):68-74. PubMed ID: 28762939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease.
    Dillinger JG; Maher V; Vitale C; Henry P; Logeart D; Manzo Silberman S; Allée G; Levy BI
    Hypertension; 2015 Dec; 66(6):1138-44. PubMed ID: 26418022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases.
    Tardif JC
    Drugs Today (Barc); 2008 Mar; 44(3):171-81. PubMed ID: 18536779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. I(f) inhibition in cardiovascular diseases.
    Thollon C; Vilaine JP
    Adv Pharmacol; 2010; 59():53-92. PubMed ID: 20933199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Ivabradine in the Treatment of Patients With Cardiovascular Disease.
    Weeda ER; Nguyen E; White CM
    Ann Pharmacother; 2016 Jun; 50(6):475-85. PubMed ID: 26917820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.